Serological assays for the detection of human Andes hantavirus infections based on its yeast-expressed nucleocapsid protein

Autores
Schmidt, J.; Meisel, H.; Capria, S. G.; Petraityte, R.; Lundkvist, Åke; Hjelle, Brian; Vial, P. A.; Padula, Paula; Kruger, D. H.; Ulrich, Rainer G.
Año de publicación
2006
Idioma
inglés
Tipo de recurso
artículo
Estado
versión publicada
Descripción
Fil: Schmidt, J. Institute of Virology, Charité School of Medicine, Berlin; Alemania.
Fil: Meisel, H. Institute of Virology, Charité School of Medicine, Berlin; Alemania.
Fil: Capria, S. G. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas. Departamento de Virología; Argentina.
Fil: Petraityte, R. Institute of Biotechnology, Vilnius; Lithuania.
Fil: Lundkvist, Åke. Swedish Institute for Infectious Disease Control and Tumorbiology Center, Karolinska Institute, Stockholm; Suecia.
Fil: Hjelle, Brian. Department of Pathology and Infectious Diseases and Inflammation Program, University of New Mexico Health Sciences Center; Estados Unidos.
Fil: Vial, P. A. Clínica Alemana School of Medicine, Institute of Science, Universidad del Desarrollo, Santiago; Chile.
Fil: Padula, Paula ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas. Departamento de Virología; Argentina.
Fil: Kruger, D. H. Institute of Virology, Charité School of Medicine, Berlin; Alemania.
Fil: Ulrich, Rainer G. Institute of Virology, Charité School of Medicine, Berlin; Alemania.
Background: The objective of the study was to develop and evaluate IgM and IgG ELISAs and an IgG Western blot test for the serological detection of human infections with Andes virus (ANDV), the major cause of hantavirus cardiopulmonary syndrome (HCPS) in South America. Methods: The entire nucleocapsid (N) protein-encoding sequence of ANDV (strain AH-1) was cloned and expressed in the yeast Saccharomyces cerevisiae. The polyhistidine-tagged recombinant N (rN) protein of ANDV was purifi ed by nickel-chelation chromatography and characterized by its reactivity with different N-specifi c monoclonal antibodies. To detect an antibody response directed against ANDV in humans, indirect IgM and IgG ELISAs and an IgG Western blot test based on ANDV rN antigen were developed. The evaluation of the tests was performed using a negative serum panel and 63 blinded sera from Argentina and Chile, containing acute-phase and convalescent sera from HCPS patients. Results: The specifi cities and sensitivities for the IgM and IgG ELISAs were demonstrated to be very high. The IgG ELISA data were confi rmed by the IgG Western blot assay based on the same rN antigen. Almost all anti-ANDVpositive sera reacted to higher endpoint titers with N protein of ANDV than with those of Sin Nombre, Laguna Negra or Puumala virus. The cross-reactivity of anti- ANDV-N IgG-positive sera to rN proteins of other hantaviruses was found to be increased with time after the onset of HCPS. Conclusion: The high sensitivity of the novel assays should facilitate early diagnosis of ANDV infections and might contribute to a successful treatment of HCPS patients.
Fuente
Intervirology 2006; 49(3): 173-184.
Materia
Hantavirus
Pruebas Serológicas
Nucleocápside
Nivel de accesibilidad
acceso abierto
Condiciones de uso
Repositorio
Sistema de Gestión del Conocimiento ANLIS MALBRÁN
Institución
Administración Nacional de Laboratorios e Institutos de Salud "Dr. Carlos G. Malbrán"
OAI Identificador
oai:sgc.anlis.gob.ar:Publications/123456789/448

id SGCANLIS_030f27d3bff1d7da7ddbded4e211f4be
oai_identifier_str oai:sgc.anlis.gob.ar:Publications/123456789/448
network_acronym_str SGCANLIS
repository_id_str a
network_name_str Sistema de Gestión del Conocimiento ANLIS MALBRÁN
spelling Serological assays for the detection of human Andes hantavirus infections based on its yeast-expressed nucleocapsid proteinSchmidt, J.Meisel, H.Capria, S. G.Petraityte, R.Lundkvist, ÅkeHjelle, BrianVial, P. A.Padula, PaulaKruger, D. H.Ulrich, Rainer G.HantavirusPruebas SerológicasNucleocápsideFil: Schmidt, J. Institute of Virology, Charité School of Medicine, Berlin; Alemania.Fil: Meisel, H. Institute of Virology, Charité School of Medicine, Berlin; Alemania.Fil: Capria, S. G. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas. Departamento de Virología; Argentina.Fil: Petraityte, R. Institute of Biotechnology, Vilnius; Lithuania.Fil: Lundkvist, Åke. Swedish Institute for Infectious Disease Control and Tumorbiology Center, Karolinska Institute, Stockholm; Suecia.Fil: Hjelle, Brian. Department of Pathology and Infectious Diseases and Inflammation Program, University of New Mexico Health Sciences Center; Estados Unidos.Fil: Vial, P. A. Clínica Alemana School of Medicine, Institute of Science, Universidad del Desarrollo, Santiago; Chile.Fil: Padula, Paula ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas. Departamento de Virología; Argentina.Fil: Kruger, D. H. Institute of Virology, Charité School of Medicine, Berlin; Alemania.Fil: Ulrich, Rainer G. Institute of Virology, Charité School of Medicine, Berlin; Alemania.Background: The objective of the study was to develop and evaluate IgM and IgG ELISAs and an IgG Western blot test for the serological detection of human infections with Andes virus (ANDV), the major cause of hantavirus cardiopulmonary syndrome (HCPS) in South America. Methods: The entire nucleocapsid (N) protein-encoding sequence of ANDV (strain AH-1) was cloned and expressed in the yeast Saccharomyces cerevisiae. The polyhistidine-tagged recombinant N (rN) protein of ANDV was purifi ed by nickel-chelation chromatography and characterized by its reactivity with different N-specifi c monoclonal antibodies. To detect an antibody response directed against ANDV in humans, indirect IgM and IgG ELISAs and an IgG Western blot test based on ANDV rN antigen were developed. The evaluation of the tests was performed using a negative serum panel and 63 blinded sera from Argentina and Chile, containing acute-phase and convalescent sera from HCPS patients. Results: The specifi cities and sensitivities for the IgM and IgG ELISAs were demonstrated to be very high. The IgG ELISA data were confi rmed by the IgG Western blot assay based on the same rN antigen. Almost all anti-ANDVpositive sera reacted to higher endpoint titers with N protein of ANDV than with those of Sin Nombre, Laguna Negra or Puumala virus. The cross-reactivity of anti- ANDV-N IgG-positive sera to rN proteins of other hantaviruses was found to be increased with time after the onset of HCPS. Conclusion: The high sensitivity of the novel assays should facilitate early diagnosis of ANDV infections and might contribute to a successful treatment of HCPS patients.Karger Publishers2006info:ar-repo/semantics/articuloinfo:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdf1423-0100http://sgc.anlis.gob.ar/handle/123456789/44810.1159/000089378Intervirology 2006; 49(3): 173-184.reponame:Sistema de Gestión del Conocimiento ANLIS MALBRÁNinstname:Administración Nacional de Laboratorios e Institutos de Salud "Dr. Carlos G. Malbrán"instacron:ANLISIntervirologyenginfo:eu-repo/semantics/openAccess2025-11-06T10:10:18Zoai:sgc.anlis.gob.ar:Publications/123456789/448Institucionalhttp://sgc.anlis.gob.ar/Organismo científico-tecnológicoNo correspondehttp://sgc.anlis.gob.ar/oai/biblioteca@anlis.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:a2025-11-06 10:10:19.297Sistema de Gestión del Conocimiento ANLIS MALBRÁN - Administración Nacional de Laboratorios e Institutos de Salud "Dr. Carlos G. Malbrán"false
dc.title.none.fl_str_mv Serological assays for the detection of human Andes hantavirus infections based on its yeast-expressed nucleocapsid protein
title Serological assays for the detection of human Andes hantavirus infections based on its yeast-expressed nucleocapsid protein
spellingShingle Serological assays for the detection of human Andes hantavirus infections based on its yeast-expressed nucleocapsid protein
Schmidt, J.
Hantavirus
Pruebas Serológicas
Nucleocápside
title_short Serological assays for the detection of human Andes hantavirus infections based on its yeast-expressed nucleocapsid protein
title_full Serological assays for the detection of human Andes hantavirus infections based on its yeast-expressed nucleocapsid protein
title_fullStr Serological assays for the detection of human Andes hantavirus infections based on its yeast-expressed nucleocapsid protein
title_full_unstemmed Serological assays for the detection of human Andes hantavirus infections based on its yeast-expressed nucleocapsid protein
title_sort Serological assays for the detection of human Andes hantavirus infections based on its yeast-expressed nucleocapsid protein
dc.creator.none.fl_str_mv Schmidt, J.
Meisel, H.
Capria, S. G.
Petraityte, R.
Lundkvist, Åke
Hjelle, Brian
Vial, P. A.
Padula, Paula
Kruger, D. H.
Ulrich, Rainer G.
author Schmidt, J.
author_facet Schmidt, J.
Meisel, H.
Capria, S. G.
Petraityte, R.
Lundkvist, Åke
Hjelle, Brian
Vial, P. A.
Padula, Paula
Kruger, D. H.
Ulrich, Rainer G.
author_role author
author2 Meisel, H.
Capria, S. G.
Petraityte, R.
Lundkvist, Åke
Hjelle, Brian
Vial, P. A.
Padula, Paula
Kruger, D. H.
Ulrich, Rainer G.
author2_role author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv Hantavirus
Pruebas Serológicas
Nucleocápside
topic Hantavirus
Pruebas Serológicas
Nucleocápside
dc.description.none.fl_txt_mv Fil: Schmidt, J. Institute of Virology, Charité School of Medicine, Berlin; Alemania.
Fil: Meisel, H. Institute of Virology, Charité School of Medicine, Berlin; Alemania.
Fil: Capria, S. G. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas. Departamento de Virología; Argentina.
Fil: Petraityte, R. Institute of Biotechnology, Vilnius; Lithuania.
Fil: Lundkvist, Åke. Swedish Institute for Infectious Disease Control and Tumorbiology Center, Karolinska Institute, Stockholm; Suecia.
Fil: Hjelle, Brian. Department of Pathology and Infectious Diseases and Inflammation Program, University of New Mexico Health Sciences Center; Estados Unidos.
Fil: Vial, P. A. Clínica Alemana School of Medicine, Institute of Science, Universidad del Desarrollo, Santiago; Chile.
Fil: Padula, Paula ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas. Departamento de Virología; Argentina.
Fil: Kruger, D. H. Institute of Virology, Charité School of Medicine, Berlin; Alemania.
Fil: Ulrich, Rainer G. Institute of Virology, Charité School of Medicine, Berlin; Alemania.
Background: The objective of the study was to develop and evaluate IgM and IgG ELISAs and an IgG Western blot test for the serological detection of human infections with Andes virus (ANDV), the major cause of hantavirus cardiopulmonary syndrome (HCPS) in South America. Methods: The entire nucleocapsid (N) protein-encoding sequence of ANDV (strain AH-1) was cloned and expressed in the yeast Saccharomyces cerevisiae. The polyhistidine-tagged recombinant N (rN) protein of ANDV was purifi ed by nickel-chelation chromatography and characterized by its reactivity with different N-specifi c monoclonal antibodies. To detect an antibody response directed against ANDV in humans, indirect IgM and IgG ELISAs and an IgG Western blot test based on ANDV rN antigen were developed. The evaluation of the tests was performed using a negative serum panel and 63 blinded sera from Argentina and Chile, containing acute-phase and convalescent sera from HCPS patients. Results: The specifi cities and sensitivities for the IgM and IgG ELISAs were demonstrated to be very high. The IgG ELISA data were confi rmed by the IgG Western blot assay based on the same rN antigen. Almost all anti-ANDVpositive sera reacted to higher endpoint titers with N protein of ANDV than with those of Sin Nombre, Laguna Negra or Puumala virus. The cross-reactivity of anti- ANDV-N IgG-positive sera to rN proteins of other hantaviruses was found to be increased with time after the onset of HCPS. Conclusion: The high sensitivity of the novel assays should facilitate early diagnosis of ANDV infections and might contribute to a successful treatment of HCPS patients.
description Fil: Schmidt, J. Institute of Virology, Charité School of Medicine, Berlin; Alemania.
publishDate 2006
dc.date.none.fl_str_mv 2006
dc.type.none.fl_str_mv info:ar-repo/semantics/articulo
info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv 1423-0100
http://sgc.anlis.gob.ar/handle/123456789/448
10.1159/000089378
identifier_str_mv 1423-0100
10.1159/000089378
url http://sgc.anlis.gob.ar/handle/123456789/448
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Intervirology
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Karger Publishers
publisher.none.fl_str_mv Karger Publishers
dc.source.none.fl_str_mv Intervirology 2006; 49(3): 173-184.
reponame:Sistema de Gestión del Conocimiento ANLIS MALBRÁN
instname:Administración Nacional de Laboratorios e Institutos de Salud "Dr. Carlos G. Malbrán"
instacron:ANLIS
reponame_str Sistema de Gestión del Conocimiento ANLIS MALBRÁN
collection Sistema de Gestión del Conocimiento ANLIS MALBRÁN
instname_str Administración Nacional de Laboratorios e Institutos de Salud "Dr. Carlos G. Malbrán"
instacron_str ANLIS
institution ANLIS
repository.name.fl_str_mv Sistema de Gestión del Conocimiento ANLIS MALBRÁN - Administración Nacional de Laboratorios e Institutos de Salud "Dr. Carlos G. Malbrán"
repository.mail.fl_str_mv biblioteca@anlis.gov.ar
_version_ 1848048316100640768
score 12.573296